TrialBioMed research international2018

Mutational Profiling of Non-Small-Cell Lung Cancer Resistant to Osimertinib Using Next-Generation Sequencing in Chinese Patients.

Keke Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.